A judge who is married to a former Pfizer executive is overseeing Mangione’s federal pretrial hearings. But she won’t oversee ...

"Federal law requires defendants to ensure that their drug labels remain accurate, and when new scientific information ...

The equity is pulling back slightly today, though it remains well above its Nov. 15 dip to $24.48 -- its lowest mark since ...

Through Dec. 20, the FDA approved 50 brand new medicines, defined as proteins, small molecules, or other chemicals this year.

Why Kirk Spano sees Pfizer as one of the next big winners from AI and why he thinks investors should be selling cash secured ...

Groninger makes thousands of fill and sealing machines for the pharmaceutical, cosmetics and consumer healthcare industries ...

Though estimated combined sales for Comirnaty and Paxlovid of $8.5 billion in 2024 will be markedly below the more than $56 ...

Pfizer Inc. closed $4.92 short of its 52-week high ($31.54), which the company reached on July 30th.

These five blue-chip dividend stocks are among the best in their respective sectors and are rated Buy at major Wall Street ...

AI stocks are stealing the spotlight today as the appetite for these services continues to gain traction globally.

Shares of Pfizer Inc. PFE inched 0.11% higher to $26.74 Tuesday, on what proved to be an all-around great trading session for ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...